View Older Stories View More Recent Stories

Apr 28, 2026 12:14PM Barclays on BridgeBio Pharma (BBIO): 'We see buying opportunity on weakness, reiterate top idea'
Apr 28, 2026 11:46AM TD Cowen on BridgeBio Pharma (BBIO): 'A key overhang is removed now'
Apr 28, 2026 11:41AM RBC Capital on BridgeBio Pharma (BBIO): 'we remain buyers'
Apr 28, 2026 11:25AM Mizuho on BridgeBio Pharma (BBIO): 'Not Best Case but Still Good Outcome Relative to Street'
Apr 28, 2026 10:53AM Morgan Stanley on Pfizer (PFE): 'we believe generic versions of Vyndaqel could still represent a potential headwind to the franchise'
Apr 28, 2026 10:17AM Pfizer extends VYNDAMAX patent protection to 2031 through settlements
Apr 28, 2026 09:48AM Mizuho: 'BBIO could potentially trade in the $90-110+ range today / near-term'
Apr 28, 2026 09:46AM RBC on Pfizer (PFE): 'Litigation overhang cleared'
Apr 28, 2026 09:38AM Barclays: 'We think dropping the question of '441 validity from the case is a major development'
Apr 24, 2026 06:59AM Bristol Myers Squibb and Pfizer partner with Mark Cuban's Cost Plus Drugs
Apr 15, 2026 06:14AM CICC Starts Pfizer (PFE) at Outperform
Apr 13, 2026 09:51AM Pfizer (PFE) PT Raised to $27 at UBS
Apr 13, 2026 06:58AM Guggenheim Reiterates Buy Rating on Pfizer (PFE)
Apr 9, 2026 09:24AM Pfizer (PFE) PT Lowered to $26 at BofA Securities
Apr 7, 2026 08:54AM RBC Capital Reiterates Underperform Rating on Pfizer (PFE)
Apr 1, 2026 03:01PM Leerink Partners on Pfizer (PFE): 'positive ruling today should drive additional Comirnaty OUS sales'
Mar 31, 2026 01:10PM Pfizer (PFE) to shutter South S.F. research site, end Bay Area presence - Bloomberg
Mar 31, 2026 06:35AM Wolfe: 'We're observing some reports of GLP-1 users refreshing their wardrobes as weight loss progresses'
Mar 24, 2026 06:31AM Pfizer (PFE) PT Raised to $36 at Guggenheim
Mar 20, 2026 04:30PM Pfizer advises shareholders to reject Tutanota mini-tender offer
Mar 19, 2026 06:45AM Pfizer's TALZENNA combination shows progress against prostate cancer
Mar 17, 2026 08:39AM Morgan Stanley on Pfizer (PFE): Atirmo Ph2 data an 'incremental positive'
Mar 17, 2026 05:42AM Stocks expected to have increasing option volume: LMND MRNA PFE BNTX NVAX AZN BMY LLY GSK JNJ MRK NVS MRK SNY
Mar 16, 2026 03:46PM US Judge blocks Trump Admin cuts to number of routinely recommended vaccines for children - Reuters
Mar 9, 2026 11:51AM BMO Capital Reiterates Outperform Rating on Pfizer (PFE) following Ph2 data
Mar 9, 2026 10:53AM FDA: 'The agency today is withdrawing final guidance titled “Scientific Considerations in Demonstrating Biosimilarity to a Reference Product'
Mar 2, 2026 07:34AM Argus Upgrades Pfizer (PFE) to Buy
Feb 27, 2026 10:04AM PADCEV plus Keytruda reduces bladder cancer recurrence risk by 47%
Feb 24, 2026 04:05PM RBC Capital Starts Pfizer (PFE) at Underperform
Feb 24, 2026 02:30PM FDA approves Pfizer's BRAFTOVI for colorectal cancer treatment
Feb 20, 2026 06:03AM Barclays Starts Pfizer (PFE) at Underweight
Feb 17, 2026 06:47AM Pfizer's BRAFTOVI shows improved survival in colorectal cancer trial
Feb 10, 2026 07:47AM Bernstein Reiterates Market Perform Rating on Pfizer (PFE)
Feb 9, 2026 10:43AM Pfizer (PFE) PT Lowered to $33 at Freedom Capital Markets
Feb 5, 2026 07:19PM Pfizer (PFE) Launches Cost Savings Program on TrumpRx
Feb 3, 2026 06:46AM Pfizer (PFE) Tops Q4 EPS by 8c, Beats on Revenue; Offers FY26 Guidance
Feb 3, 2026 06:40AM Pfizer obesity drug shows 12.3% weight loss in phase 2b trial
Feb 3, 2026 12:00AM Pfizer earnings preview Q4: softer print expected, drug pipeline in focus
Feb 2, 2026 10:31AM Pfizer (PFE) call put ratio 2.2 calls to 1 put into quarter results
Feb 2, 2026 05:10AM Pfizer (PFE) call put ratio 3.3 calls to 1 put into quarter results
Jan 30, 2026 11:19AM Pfizer (PFE) call put ratio 2.5 calls to 1 put into quarter results
Jan 27, 2026 04:48PM Eli Lilly, Pfizer, AbbVie drugs targeted in third Medicare price talks
Jan 23, 2026 06:29AM Goldman Sachs Previews Pfizer (PFE) Earnings
Jan 20, 2026 09:33AM Bernstein Reiterates Market Perform Rating on Pfizer (PFE)
Jan 19, 2026 06:52PM Shionogi Invests $2.1 bln To Raise Stake in Viiv Healthcare - Bloomberg
Jan 12, 2026 01:16PM Pfizer (PFE) CEO: to launch next-gen obesity assets acquired through Metsera buyout in 2028 - JPM Conference
Jan 12, 2026 04:09AM Pfizer's BRAFTOVI shows improved response rates in colorectal cancer trial
Jan 8, 2026 11:14AM Pfizer (PFE) call put ratio 1.2 calls to 1 put into the annual J.P. Morgan Healthcare Conference
Jan 7, 2026 12:26AM UBS Assumes Pfizer (PFE) at Neutral
Dec 31, 2025 08:50AM FDA revokes emergency use authorizations (EMAs) issued to Pfizer for lucira by Pfizer Covid-19 & flu test
View More Recent Stories View Older Stories